|
Condensed Consolidating Financial Statements Cash Flows (Details) (USD $)
In Thousands, unless otherwise specified
|
12 Months Ended |
|
Dec. 31, 2014
|
Dec. 31, 2013
|
Dec. 31, 2012
|
| Cash flows from operating activities: |
|
|
|
| Net cash provided (used) by operating activities |
$ 590,181 |
$ 475,421 |
$ 249,733 |
| Cash flows from investing activities: |
|
|
|
| Acquisitions, net of cash acquired |
(2,026) |
(388,866) |
(1,565,705) |
| Purchases of property and equipment |
(78,078) |
(128,842) |
(40,236) |
| Proceeds from restricted cash |
20,006 |
20,004 |
0 |
| Net cash used in investing activities |
(60,098) |
(497,704) |
(1,605,941) |
| Cash flows from financing activities: |
|
|
|
| Proceeds from issuance of debt |
492,500 |
450,000 |
1,475,448 |
| Repayment of long-term debt |
(337,500) |
(362,500) |
(616,993) |
| Proceeds from public offering, net of issuance costs |
0 |
0 |
519,075 |
| Payment of financing costs |
(1,963) |
(2,347) |
(18,806) |
| Proceeds from exercise of options and warrants |
|
3,479 |
7,763 |
| Proceeds from exercise of options |
5,639 |
2,992 |
7,763 |
| Tax benefit on option exercises |
3,492 |
9,732 |
19,397 |
| Proceeds from warrants exercised |
3,452 |
487 |
0 |
| Payments of contingent consideration |
(18,338) |
(23,203) |
|
| Distribution to non-controlling interest |
(52,309) |
(36,314) |
0 |
| Net transactions with parent and affiliates |
0 |
0 |
0 |
| Proceeds from restricted stock |
0 |
0 |
0 |
| Other |
(383) |
0 |
(268) |
| Net cash provided by financing activities |
94,590 |
38,847 |
1,385,616 |
| Effect of foreign exchange on cash balances |
38 |
(99) |
(14) |
| Increase in cash and cash equivalents |
624,711 |
16,465 |
29,394 |
| Cash and cash equivalents, beginning of period |
387,241 |
370,776 |
341,382 |
| Cash and cash equivalents, end of period |
1,011,952 |
387,241 |
370,776 |
| Reportable Legal Entities | Catamaran Corporation |
|
|
|
| Cash flows from operating activities: |
|
|
|
| Net cash provided (used) by operating activities |
341,698 |
186,985 |
(27,257) |
| Cash flows from investing activities: |
|
|
|
| Acquisitions, net of cash acquired |
0 |
0 |
3,644,364 |
| Purchases of property and equipment |
(71) |
(11) |
(66) |
| Proceeds from restricted cash |
0 |
0 |
|
| Net cash used in investing activities |
(71) |
(11) |
3,644,298 |
| Cash flows from financing activities: |
|
|
|
| Proceeds from issuance of debt |
492,500 |
450,000 |
1,475,448 |
| Repayment of long-term debt |
(337,500) |
(362,500) |
(616,993) |
| Proceeds from public offering, net of issuance costs |
|
|
519,075 |
| Payment of financing costs |
(1,963) |
(2,347) |
(18,806) |
| Proceeds from exercise of options and warrants |
|
4,729 |
11,016 |
| Proceeds from exercise of options |
8,011 |
|
|
| Tax benefit on option exercises |
0 |
0 |
0 |
| Proceeds from warrants exercised |
3,452 |
|
|
| Payments of contingent consideration |
0 |
0 |
|
| Distribution to non-controlling interest |
0 |
0 |
|
| Net transactions with parent and affiliates |
(208,486) |
(322,377) |
(5,093,214) |
| Proceeds from restricted stock |
20,700 |
27,107 |
17,903 |
| Other |
0 |
0 |
(268) |
| Net cash provided by financing activities |
(23,286) |
(205,388) |
(3,705,839) |
| Effect of foreign exchange on cash balances |
38 |
(99) |
(14) |
| Increase in cash and cash equivalents |
318,379 |
(18,513) |
(88,812) |
| Cash and cash equivalents, beginning of period |
15,090 |
33,603 |
122,415 |
| Cash and cash equivalents, end of period |
333,469 |
15,090 |
33,603 |
| Reportable Legal Entities | Guarantors |
|
|
|
| Cash flows from operating activities: |
|
|
|
| Net cash provided (used) by operating activities |
612,430 |
616,168 |
430,091 |
| Cash flows from investing activities: |
|
|
|
| Acquisitions, net of cash acquired |
(2,026) |
(388,866) |
(5,210,069) |
| Purchases of property and equipment |
(41,664) |
(117,799) |
(30,549) |
| Proceeds from restricted cash |
20,006 |
20,004 |
|
| Net cash used in investing activities |
(23,684) |
(486,661) |
(5,240,618) |
| Cash flows from financing activities: |
|
|
|
| Proceeds from issuance of debt |
0 |
0 |
0 |
| Repayment of long-term debt |
0 |
0 |
0 |
| Proceeds from public offering, net of issuance costs |
|
|
0 |
| Payment of financing costs |
0 |
0 |
0 |
| Proceeds from exercise of options and warrants |
|
(1,248) |
(3,253) |
| Proceeds from exercise of options |
(2,355) |
|
|
| Tax benefit on option exercises |
3,455 |
9,704 |
19,206 |
| Proceeds from warrants exercised |
0 |
|
|
| Payments of contingent consideration |
(18,338) |
(18,338) |
|
| Distribution to non-controlling interest |
0 |
0 |
|
| Net transactions with parent and affiliates |
(264,620) |
(49,103) |
4,913,963 |
| Proceeds from restricted stock |
(20,249) |
(26,645) |
(17,651) |
| Other |
(383) |
0 |
0 |
| Net cash provided by financing activities |
(302,490) |
(85,630) |
4,912,265 |
| Effect of foreign exchange on cash balances |
0 |
0 |
0 |
| Increase in cash and cash equivalents |
286,256 |
43,877 |
101,738 |
| Cash and cash equivalents, beginning of period |
362,647 |
318,770 |
217,032 |
| Cash and cash equivalents, end of period |
648,903 |
362,647 |
318,770 |
| Reportable Legal Entities | Non-Guarantors |
|
|
|
| Cash flows from operating activities: |
|
|
|
| Net cash provided (used) by operating activities |
(6,952) |
(30,476) |
(18,449) |
| Cash flows from investing activities: |
|
|
|
| Acquisitions, net of cash acquired |
0 |
0 |
0 |
| Purchases of property and equipment |
(36,343) |
(11,032) |
(9,621) |
| Proceeds from restricted cash |
0 |
0 |
|
| Net cash used in investing activities |
(36,343) |
(11,032) |
(9,621) |
| Cash flows from financing activities: |
|
|
|
| Proceeds from issuance of debt |
0 |
0 |
0 |
| Repayment of long-term debt |
0 |
0 |
0 |
| Proceeds from public offering, net of issuance costs |
|
|
0 |
| Payment of financing costs |
0 |
0 |
0 |
| Proceeds from exercise of options and warrants |
|
(2) |
0 |
| Proceeds from exercise of options |
(17) |
|
|
| Tax benefit on option exercises |
37 |
28 |
191 |
| Proceeds from warrants exercised |
0 |
|
|
| Payments of contingent consideration |
0 |
(4,865) |
|
| Distribution to non-controlling interest |
0 |
0 |
|
| Net transactions with parent and affiliates |
63,802 |
37,910 |
44,599 |
| Proceeds from restricted stock |
(451) |
(462) |
(252) |
| Other |
0 |
0 |
0 |
| Net cash provided by financing activities |
63,371 |
32,609 |
44,538 |
| Effect of foreign exchange on cash balances |
0 |
0 |
0 |
| Increase in cash and cash equivalents |
20,076 |
(8,899) |
16,468 |
| Cash and cash equivalents, beginning of period |
9,504 |
18,403 |
1,935 |
| Cash and cash equivalents, end of period |
29,580 |
9,504 |
18,403 |
| Consolidations |
|
|
|
| Cash flows from operating activities: |
|
|
|
| Net cash provided (used) by operating activities |
(356,995) |
(297,256) |
(134,652) |
| Cash flows from investing activities: |
|
|
|
| Acquisitions, net of cash acquired |
0 |
0 |
0 |
| Purchases of property and equipment |
0 |
0 |
|
| Proceeds from restricted cash |
0 |
0 |
|
| Net cash used in investing activities |
0 |
0 |
0 |
| Cash flows from financing activities: |
|
|
|
| Proceeds from issuance of debt |
0 |
0 |
0 |
| Repayment of long-term debt |
0 |
0 |
0 |
| Proceeds from public offering, net of issuance costs |
|
|
0 |
| Payment of financing costs |
0 |
0 |
0 |
| Proceeds from exercise of options and warrants |
|
0 |
0 |
| Proceeds from exercise of options |
0 |
|
|
| Tax benefit on option exercises |
0 |
0 |
0 |
| Proceeds from warrants exercised |
0 |
|
|
| Payments of contingent consideration |
0 |
0 |
|
| Distribution to non-controlling interest |
(52,309) |
(36,314) |
|
| Net transactions with parent and affiliates |
409,304 |
333,570 |
134,652 |
| Proceeds from restricted stock |
0 |
0 |
0 |
| Other |
0 |
0 |
0 |
| Net cash provided by financing activities |
356,995 |
297,256 |
134,652 |
| Effect of foreign exchange on cash balances |
0 |
0 |
0 |
| Increase in cash and cash equivalents |
0 |
0 |
0 |
| Cash and cash equivalents, beginning of period |
0 |
0 |
0 |
| Cash and cash equivalents, end of period |
$ 0 |
$ 0 |
$ 0 |